Sandbox GGC5: Difference between revisions
From Proteopedia
Jump to navigationJump to search
James Nolan (talk | contribs) No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
== Disease == | == Disease == | ||
Pulmonary Embolism | |||
Acute Myocardial Infarction | |||
== Relevance == | == Relevance == | ||
== Structural highlights == | == Structural highlights == | ||
residue (purine) | |||
aromatic | |||
ligands | |||
Revision as of 20:17, 18 November 2019
FABP3 with myristic acid
| ||||||||||||
References
<references/Matsuoka, Shigeru, et al. “Water-Mediated Recognition of Simple Alkyl Chains by Heart-Type Fatty-Acid-Binding Protein.” Angewandte Chemie International Edition, vol. 54, no. 5, 2014, pp. 1508–1511., doi:10.1002/anie.201409830.> <references/Myristic acid and Lauric acid. https://www.acs.org/content/acs/en/molecule-of-the-week/archive/m/myristic-acid.html (accessed Nov 6, 2019).> <references/National Center for Biotechnology Information. PubChem Database. Myristic acid, CID=11005, https://pubchem.ncbi.nlm.nih.gov/compound/Myristic-acid (accessed on Nov. 6, 2019)>